nodes	percent_of_prediction	percent_of_DWPC	metapath
Probenecid—ABCC6—Dactinomycin—melanoma	0.196	0.334	CbGbCtD
Probenecid—ALB—melanoma	0.108	0.512	CbGaD
Probenecid—ABCB1—melanoma	0.104	0.488	CbGaD
Probenecid—ABCC1—Vemurafenib—melanoma	0.0869	0.148	CbGbCtD
Probenecid—ABCC1—Dactinomycin—melanoma	0.0577	0.0985	CbGbCtD
Probenecid—SLC22A5—Dactinomycin—melanoma	0.0549	0.0937	CbGbCtD
Probenecid—ALB—Vemurafenib—melanoma	0.0401	0.0684	CbGbCtD
Probenecid—SLC22A7—Docetaxel—melanoma	0.038	0.0648	CbGbCtD
Probenecid—ABCC1—Docetaxel—melanoma	0.0298	0.0509	CbGbCtD
Probenecid—CYP3A4—Temozolomide—melanoma	0.0229	0.0391	CbGbCtD
Probenecid—ABCC2—Docetaxel—melanoma	0.0221	0.0377	CbGbCtD
Probenecid—ABCB1—Dactinomycin—melanoma	0.0139	0.0238	CbGbCtD
Probenecid—CYP3A4—Vemurafenib—melanoma	0.0126	0.0214	CbGbCtD
Probenecid—ABCC6—dermis—melanoma	0.00749	0.213	CbGeAlD
Probenecid—ABCB1—Docetaxel—melanoma	0.00719	0.0123	CbGbCtD
Probenecid—CYP3A4—Docetaxel—melanoma	0.00431	0.00735	CbGbCtD
Probenecid—SLC2A9—hair follicle—melanoma	0.0037	0.105	CbGeAlD
Probenecid—SLC22A8—optic choroid—melanoma	0.00261	0.0739	CbGeAlD
Probenecid—PANX1—mammalian vulva—melanoma	0.00162	0.0459	CbGeAlD
Probenecid—ABCC5—hair follicle—melanoma	0.00153	0.0434	CbGeAlD
Probenecid—Procainamide—SCN11A—melanoma	0.00152	0.287	CrCbGaD
Probenecid—Toxic epidermal necrolysis—Vemurafenib—melanoma	0.00127	0.0322	CcSEcCtD
Probenecid—PANX1—head—melanoma	0.00116	0.0328	CbGeAlD
Probenecid—ABCC6—eye—melanoma	0.00112	0.0318	CbGeAlD
Probenecid—ABCC6—retina—melanoma	0.00111	0.0316	CbGeAlD
Probenecid—Procaine—SCN10A—melanoma	0.0011	0.209	CrCbGaD
Probenecid—Stevens-Johnson syndrome—Vemurafenib—melanoma	0.00108	0.0273	CcSEcCtD
Probenecid—Aplastic anaemia—Dactinomycin—melanoma	0.00103	0.0261	CcSEcCtD
Probenecid—Chlorpropamide—SLC15A2—melanoma	0.000961	0.182	CrCbGaD
Probenecid—Tolbutamide—SLC15A2—melanoma	0.000936	0.177	CrCbGaD
Probenecid—Aplastic anaemia—Temozolomide—melanoma	0.000931	0.0236	CcSEcCtD
Probenecid—Erythema multiforme—Vemurafenib—melanoma	0.000921	0.0234	CcSEcCtD
Probenecid—ABCC1—hair follicle—melanoma	0.000903	0.0256	CbGeAlD
Probenecid—SLC16A7—mammalian vulva—melanoma	0.000865	0.0245	CbGeAlD
Probenecid—Alopecia—Vemurafenib—melanoma	0.000861	0.0219	CcSEcCtD
Probenecid—PANX1—lymph node—melanoma	0.00081	0.023	CbGeAlD
Probenecid—ABCC5—retina—melanoma	0.000756	0.0214	CbGeAlD
Probenecid—SLC2A9—lymph node—melanoma	0.000734	0.0208	CbGeAlD
Probenecid—Toxic epidermal necrolysis—Dactinomycin—melanoma	0.000716	0.0182	CcSEcCtD
Probenecid—SLC16A1—eye—melanoma	0.000694	0.0197	CbGeAlD
Probenecid—Anaphylactic shock—Vemurafenib—melanoma	0.000692	0.0176	CcSEcCtD
Probenecid—SLC16A1—retina—melanoma	0.000688	0.0195	CbGeAlD
Probenecid—Toxic epidermal necrolysis—Temozolomide—melanoma	0.000648	0.0165	CcSEcCtD
Probenecid—ABCC6—head—melanoma	0.000637	0.0181	CbGeAlD
Probenecid—Haematuria—Bleomycin—melanoma	0.000627	0.0159	CcSEcCtD
Probenecid—SLC16A7—head—melanoma	0.000619	0.0176	CbGeAlD
Probenecid—Stevens-Johnson syndrome—Dactinomycin—melanoma	0.000608	0.0154	CcSEcCtD
Probenecid—Decreased appetite—Vemurafenib—melanoma	0.000602	0.0153	CcSEcCtD
Probenecid—SLC10A1—head—melanoma	0.000578	0.0164	CbGeAlD
Probenecid—Pollakiuria—Temozolomide—melanoma	0.000575	0.0146	CcSEcCtD
Probenecid—Procainamide—SCN10A—melanoma	0.000571	0.108	CrCbGaD
Probenecid—Stevens-Johnson syndrome—Temozolomide—melanoma	0.00055	0.014	CcSEcCtD
Probenecid—Flushing—Bleomycin—melanoma	0.000548	0.0139	CcSEcCtD
Probenecid—Body temperature increased—Vemurafenib—melanoma	0.000547	0.0139	CcSEcCtD
Probenecid—SLCO1C1—head—melanoma	0.000543	0.0154	CbGeAlD
Probenecid—SLC22A8—eye—melanoma	0.000524	0.0149	CbGeAlD
Probenecid—Alopecia—Bleomycin—melanoma	0.000522	0.0132	CcSEcCtD
Probenecid—Erythema multiforme—Dactinomycin—melanoma	0.00052	0.0132	CcSEcCtD
Probenecid—Flushing—Dactinomycin—melanoma	0.000511	0.013	CcSEcCtD
Probenecid—Hypersensitivity—Vemurafenib—melanoma	0.00051	0.0129	CcSEcCtD
Probenecid—Pruritus—Vemurafenib—melanoma	0.00049	0.0124	CcSEcCtD
Probenecid—Alopecia—Dactinomycin—melanoma	0.000486	0.0123	CcSEcCtD
Probenecid—Flushing—Carmustine—melanoma	0.000478	0.0121	CcSEcCtD
Probenecid—Anaemia—Bleomycin—melanoma	0.000475	0.0121	CcSEcCtD
Probenecid—Erythema multiforme—Temozolomide—melanoma	0.000471	0.012	CcSEcCtD
Probenecid—Flushing—Temozolomide—melanoma	0.000462	0.0117	CcSEcCtD
Probenecid—Leukopenia—Bleomycin—melanoma	0.00046	0.0117	CcSEcCtD
Probenecid—Dizziness—Vemurafenib—melanoma	0.000458	0.0116	CcSEcCtD
Probenecid—Alopecia—Carmustine—melanoma	0.000455	0.0116	CcSEcCtD
Probenecid—Anaemia—Dactinomycin—melanoma	0.000443	0.0112	CcSEcCtD
Probenecid—Vomiting—Vemurafenib—melanoma	0.00044	0.0112	CcSEcCtD
Probenecid—Alopecia—Temozolomide—melanoma	0.00044	0.0112	CcSEcCtD
Probenecid—Dermatitis—Vemurafenib—melanoma	0.000436	0.0111	CcSEcCtD
Probenecid—Headache—Vemurafenib—melanoma	0.000434	0.011	CcSEcCtD
Probenecid—SLC16A7—lymph node—melanoma	0.000433	0.0123	CbGeAlD
Probenecid—Toxic epidermal necrolysis—Docetaxel—melanoma	0.000431	0.0109	CcSEcCtD
Probenecid—Leukopenia—Dactinomycin—melanoma	0.000429	0.0109	CcSEcCtD
Probenecid—Anaphylactic shock—Bleomycin—melanoma	0.000419	0.0106	CcSEcCtD
Probenecid—Anaemia—Carmustine—melanoma	0.000414	0.0105	CcSEcCtD
Probenecid—Nausea—Vemurafenib—melanoma	0.000411	0.0104	CcSEcCtD
Probenecid—Leukopenia—Carmustine—melanoma	0.000401	0.0102	CcSEcCtD
Probenecid—Anaemia—Temozolomide—melanoma	0.000401	0.0102	CcSEcCtD
Probenecid—Anorexia—Bleomycin—melanoma	0.0004	0.0101	CcSEcCtD
Probenecid—SLC16A1—head—melanoma	0.000394	0.0112	CbGeAlD
Probenecid—SLC22A5—retina—melanoma	0.000393	0.0111	CbGeAlD
Probenecid—Leukopenia—Temozolomide—melanoma	0.000388	0.00985	CcSEcCtD
Probenecid—SLCO1C1—lymph node—melanoma	0.00038	0.0108	CbGeAlD
Probenecid—Anorexia—Dactinomycin—melanoma	0.000373	0.00946	CcSEcCtD
Probenecid—Stevens-Johnson syndrome—Docetaxel—melanoma	0.000366	0.00928	CcSEcCtD
Probenecid—Decreased appetite—Bleomycin—melanoma	0.000364	0.00925	CcSEcCtD
Probenecid—ABCC3—head—melanoma	0.000364	0.0103	CbGeAlD
Probenecid—Pain—Bleomycin—melanoma	0.000359	0.0091	CcSEcCtD
Probenecid—ABCC1—mammalian vulva—melanoma	0.000358	0.0101	CbGeAlD
Probenecid—Anaphylactic shock—Temozolomide—melanoma	0.000354	0.00898	CcSEcCtD
Probenecid—Anorexia—Carmustine—melanoma	0.000349	0.00886	CcSEcCtD
Probenecid—ABCB1—blood vessel—melanoma	0.000346	0.00981	CbGeAlD
Probenecid—SLC22A5—skin of body—melanoma	0.000345	0.00979	CbGeAlD
Probenecid—Decreased appetite—Dactinomycin—melanoma	0.00034	0.00863	CcSEcCtD
Probenecid—Anorexia—Temozolomide—melanoma	0.000337	0.00856	CcSEcCtD
Probenecid—Pain—Dactinomycin—melanoma	0.000334	0.00849	CcSEcCtD
Probenecid—Urticaria—Bleomycin—melanoma	0.000333	0.00846	CcSEcCtD
Probenecid—Body temperature increased—Bleomycin—melanoma	0.000331	0.00842	CcSEcCtD
Probenecid—SLC22A1—head—melanoma	0.000324	0.00919	CbGeAlD
Probenecid—Decreased appetite—Carmustine—melanoma	0.000318	0.00808	CcSEcCtD
Probenecid—Erythema multiforme—Docetaxel—melanoma	0.000313	0.00795	CcSEcCtD
Probenecid—Pain—Carmustine—melanoma	0.000313	0.00795	CcSEcCtD
Probenecid—SLCO1A2—head—melanoma	0.000312	0.00885	CbGeAlD
Probenecid—Body temperature increased—Dactinomycin—melanoma	0.000309	0.00785	CcSEcCtD
Probenecid—Hypersensitivity—Bleomycin—melanoma	0.000309	0.00784	CcSEcCtD
Probenecid—Decreased appetite—Temozolomide—melanoma	0.000307	0.00781	CcSEcCtD
Probenecid—Flushing—Docetaxel—melanoma	0.000307	0.0078	CcSEcCtD
Probenecid—ABCC5—lymph node—melanoma	0.000303	0.0086	CbGeAlD
Probenecid—Pain—Temozolomide—melanoma	0.000302	0.00768	CcSEcCtD
Probenecid—ABCC4—head—melanoma	0.0003	0.00852	CbGeAlD
Probenecid—SLC22A8—head—melanoma	0.000298	0.00845	CbGeAlD
Probenecid—Pruritus—Bleomycin—melanoma	0.000297	0.00753	CcSEcCtD
Probenecid—Alopecia—Docetaxel—melanoma	0.000293	0.00743	CcSEcCtD
Probenecid—Body temperature increased—Carmustine—melanoma	0.000289	0.00735	CcSEcCtD
Probenecid—Hypersensitivity—Dactinomycin—melanoma	0.000288	0.00731	CcSEcCtD
Probenecid—Urticaria—Temozolomide—melanoma	0.000281	0.00713	CcSEcCtD
Probenecid—Body temperature increased—Temozolomide—melanoma	0.00028	0.0071	CcSEcCtD
Probenecid—SLC16A1—lymph node—melanoma	0.000276	0.00783	CbGeAlD
Probenecid—Hypersensitivity—Carmustine—melanoma	0.00027	0.00685	CcSEcCtD
Probenecid—Vomiting—Bleomycin—melanoma	0.000267	0.00677	CcSEcCtD
Probenecid—Anaemia—Docetaxel—melanoma	0.000266	0.00676	CcSEcCtD
Probenecid—Dermatitis—Bleomycin—melanoma	0.000264	0.00671	CcSEcCtD
Probenecid—Hypersensitivity—Temozolomide—melanoma	0.000261	0.00662	CcSEcCtD
Probenecid—Leukopenia—Docetaxel—melanoma	0.000258	0.00655	CcSEcCtD
Probenecid—ABCC3—lymph node—melanoma	0.000255	0.00722	CbGeAlD
Probenecid—Pruritus—Temozolomide—melanoma	0.00025	0.00635	CcSEcCtD
Probenecid—Nausea—Bleomycin—melanoma	0.000249	0.00632	CcSEcCtD
Probenecid—Vomiting—Dactinomycin—melanoma	0.000249	0.00631	CcSEcCtD
Probenecid—Dizziness—Carmustine—melanoma	0.000242	0.00614	CcSEcCtD
Probenecid—Anaphylactic shock—Docetaxel—melanoma	0.000235	0.00597	CcSEcCtD
Probenecid—Dizziness—Temozolomide—melanoma	0.000234	0.00594	CcSEcCtD
Probenecid—Vomiting—Carmustine—melanoma	0.000233	0.00591	CcSEcCtD
Probenecid—Nausea—Dactinomycin—melanoma	0.000232	0.0059	CcSEcCtD
Probenecid—Dermatitis—Carmustine—melanoma	0.000231	0.00585	CcSEcCtD
Probenecid—Headache—Carmustine—melanoma	0.000229	0.00582	CcSEcCtD
Probenecid—Vomiting—Temozolomide—melanoma	0.000225	0.00571	CcSEcCtD
Probenecid—Anorexia—Docetaxel—melanoma	0.000224	0.00569	CcSEcCtD
Probenecid—Dermatitis—Temozolomide—melanoma	0.000223	0.00566	CcSEcCtD
Probenecid—Headache—Temozolomide—melanoma	0.000222	0.00563	CcSEcCtD
Probenecid—Nausea—Carmustine—melanoma	0.000217	0.00552	CcSEcCtD
Probenecid—ALB—lymph node—melanoma	0.000217	0.00616	CbGeAlD
Probenecid—ABCC4—lymph node—melanoma	0.00021	0.00596	CbGeAlD
Probenecid—Nausea—Temozolomide—melanoma	0.00021	0.00533	CcSEcCtD
Probenecid—Decreased appetite—Docetaxel—melanoma	0.000204	0.00519	CcSEcCtD
Probenecid—ABCC2—lymph node—melanoma	0.000203	0.00577	CbGeAlD
Probenecid—Pain—Docetaxel—melanoma	0.000201	0.00511	CcSEcCtD
Probenecid—Chlorpropamide—ABCB1—melanoma	0.000197	0.0373	CrCbGaD
Probenecid—Body temperature increased—Docetaxel—melanoma	0.000186	0.00472	CcSEcCtD
Probenecid—ABCB1—retina—melanoma	0.000182	0.00517	CbGeAlD
Probenecid—ABCC1—lymph node—melanoma	0.000179	0.00508	CbGeAlD
Probenecid—Hypersensitivity—Docetaxel—melanoma	0.000173	0.0044	CcSEcCtD
Probenecid—Pruritus—Docetaxel—melanoma	0.000166	0.00422	CcSEcCtD
Probenecid—SLC22A5—lymph node—melanoma	0.000158	0.00447	CbGeAlD
Probenecid—Dizziness—Docetaxel—melanoma	0.000156	0.00395	CcSEcCtD
Probenecid—Vomiting—Docetaxel—melanoma	0.00015	0.0038	CcSEcCtD
Probenecid—Dermatitis—Docetaxel—melanoma	0.000148	0.00376	CcSEcCtD
Probenecid—Headache—Docetaxel—melanoma	0.000147	0.00374	CcSEcCtD
Probenecid—ABCB1—mammalian vulva—melanoma	0.000146	0.00414	CbGeAlD
Probenecid—Nausea—Docetaxel—melanoma	0.00014	0.00355	CcSEcCtD
Probenecid—ABCB1—head—melanoma	0.000104	0.00296	CbGeAlD
Probenecid—ABCB1—lymph node—melanoma	7.31e-05	0.00208	CbGeAlD
Probenecid—ABCC1—Disease—BRAF—melanoma	5.66e-06	4.64e-05	CbGpPWpGaD
Probenecid—ABCC3—Metabolism—PIK3CD—melanoma	5.65e-06	4.64e-05	CbGpPWpGaD
Probenecid—ABCC5—Disease—MAPK1—melanoma	5.61e-06	4.6e-05	CbGpPWpGaD
Probenecid—ABCC5—Disease—EGFR—melanoma	5.61e-06	4.6e-05	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—PRKCA—melanoma	5.6e-06	4.6e-05	CbGpPWpGaD
Probenecid—SLCO1A2—Metabolism—PIK3CG—melanoma	5.6e-06	4.6e-05	CbGpPWpGaD
Probenecid—ABCC3—Metabolism—ALB—melanoma	5.58e-06	4.58e-05	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—ERCC2—melanoma	5.56e-06	4.56e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	5.52e-06	4.53e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—CYP17A1—melanoma	5.51e-06	4.52e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—CYP17A1—melanoma	5.48e-06	4.5e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	5.43e-06	4.46e-05	CbGpPWpGaD
Probenecid—SLCO1A2—Metabolism—PPARG—melanoma	5.4e-06	4.44e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	5.4e-06	4.43e-05	CbGpPWpGaD
Probenecid—SLC16A1—Metabolism—PTEN—melanoma	5.37e-06	4.41e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism of lipids and lipoproteins—ALB—melanoma	5.36e-06	4.4e-05	CbGpPWpGaD
Probenecid—ABCC1—Disease—MAP2K1—melanoma	5.32e-06	4.37e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—melanoma	5.32e-06	4.37e-05	CbGpPWpGaD
Probenecid—SLC10A1—Metabolism—PIK3CA—melanoma	5.32e-06	4.36e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—VCAN—melanoma	5.31e-06	4.36e-05	CbGpPWpGaD
Probenecid—ABCC5—Disease—KRAS—melanoma	5.3e-06	4.35e-05	CbGpPWpGaD
Probenecid—ABCC1—Disease—PIK3CD—melanoma	5.29e-06	4.34e-05	CbGpPWpGaD
Probenecid—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	5.29e-06	4.34e-05	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—PRKCA—melanoma	5.22e-06	4.29e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—GNA11—melanoma	5.2e-06	4.27e-05	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—ERCC2—melanoma	5.18e-06	4.25e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—GNA11—melanoma	5.17e-06	4.25e-05	CbGpPWpGaD
Probenecid—ALB—Hemostasis—PIK3CB—melanoma	5.17e-06	4.24e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—PHGDH—melanoma	5.1e-06	4.18e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—LUM—melanoma	5.1e-06	4.18e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—FASN—melanoma	5.09e-06	4.18e-05	CbGpPWpGaD
Probenecid—ABCC1—Disease—FGF2—melanoma	5.06e-06	4.16e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—FASN—melanoma	5.06e-06	4.15e-05	CbGpPWpGaD
Probenecid—ABCC1—Metabolism—PIK3CG—melanoma	5.04e-06	4.14e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	5.03e-06	4.13e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—SLC5A5—melanoma	5.01e-06	4.11e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—HPSE—melanoma	5e-06	4.1e-05	CbGpPWpGaD
Probenecid—ALB—Platelet activation, signaling and aggregation—AKT1—melanoma	5e-06	4.1e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—SLC5A5—melanoma	4.98e-06	4.09e-05	CbGpPWpGaD
Probenecid—ABCC3—Metabolism—PIK3CB—melanoma	4.93e-06	4.05e-05	CbGpPWpGaD
Probenecid—SLCO1A2—Metabolism—PIK3CD—melanoma	4.92e-06	4.04e-05	CbGpPWpGaD
Probenecid—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	4.92e-06	4.04e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—CYP17A1—melanoma	4.92e-06	4.04e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—CUBN—melanoma	4.9e-06	4.03e-05	CbGpPWpGaD
Probenecid—ABCC3—Metabolism—PTGS2—melanoma	4.88e-06	4.01e-05	CbGpPWpGaD
Probenecid—ABCC5—Disease—PIK3CA—melanoma	4.87e-06	3.99e-05	CbGpPWpGaD
Probenecid—ABCC1—Metabolism—PPARG—melanoma	4.86e-06	3.99e-05	CbGpPWpGaD
Probenecid—SLCO1A2—Metabolism—ALB—melanoma	4.86e-06	3.99e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—melanoma	4.85e-06	3.98e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	4.85e-06	3.98e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—GNAQ—melanoma	4.84e-06	3.97e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—CD44—melanoma	4.84e-06	3.97e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—GNAQ—melanoma	4.81e-06	3.95e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—CD44—melanoma	4.81e-06	3.95e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—CYP17A1—melanoma	4.8e-06	3.94e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism of lipids and lipoproteins—ALB—melanoma	4.79e-06	3.93e-05	CbGpPWpGaD
Probenecid—ALB—Hemostasis—IL2—melanoma	4.75e-06	3.9e-05	CbGpPWpGaD
Probenecid—ABCC1—Disease—MDM2—melanoma	4.74e-06	3.89e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—SDHD—melanoma	4.74e-06	3.89e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—CSPG4—melanoma	4.74e-06	3.89e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—BSG—melanoma	4.74e-06	3.89e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	4.73e-06	3.89e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	4.71e-06	3.86e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—melanoma	4.69e-06	3.85e-05	CbGpPWpGaD
Probenecid—ABCC1—Disease—ERBB2—melanoma	4.67e-06	3.84e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism of lipids and lipoproteins—PTGS2—melanoma	4.66e-06	3.83e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—GNA11—melanoma	4.64e-06	3.81e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—CYP1B1—melanoma	4.64e-06	3.81e-05	CbGpPWpGaD
Probenecid—ABCC1—Disease—PIK3CB—melanoma	4.61e-06	3.78e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—CYP1B1—melanoma	4.61e-06	3.78e-05	CbGpPWpGaD
Probenecid—ABCC1—Disease—CD4—melanoma	4.6e-06	3.78e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—GPAM—melanoma	4.59e-06	3.77e-05	CbGpPWpGaD
Probenecid—ABCC1—Disease—PTGS2—melanoma	4.57e-06	3.75e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—FASN—melanoma	4.54e-06	3.73e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—GNA11—melanoma	4.53e-06	3.72e-05	CbGpPWpGaD
Probenecid—ABCC5—Disease—HRAS—melanoma	4.5e-06	3.7e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—CYP17A1—melanoma	4.48e-06	3.68e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—SLC5A5—melanoma	4.47e-06	3.67e-05	CbGpPWpGaD
Probenecid—ABCB1—Transmembrane transport of small molecules—ALB—melanoma	4.44e-06	3.65e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—FASN—melanoma	4.43e-06	3.64e-05	CbGpPWpGaD
Probenecid—ABCC1—Metabolism—PIK3CD—melanoma	4.43e-06	3.64e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	4.42e-06	3.63e-05	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—PIK3CG—melanoma	4.39e-06	3.6e-05	CbGpPWpGaD
Probenecid—ABCC1—Metabolism—ALB—melanoma	4.37e-06	3.59e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism of lipids and lipoproteins—ALB—melanoma	4.36e-06	3.58e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—SLC5A5—melanoma	4.36e-06	3.58e-05	CbGpPWpGaD
Probenecid—SLC10A1—Metabolism—AKT1—melanoma	4.34e-06	3.57e-05	CbGpPWpGaD
Probenecid—ABCC1—Disease—CDKN1B—melanoma	4.33e-06	3.55e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—GNAQ—melanoma	4.32e-06	3.54e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—CD44—melanoma	4.32e-06	3.54e-05	CbGpPWpGaD
Probenecid—ABCC5—Disease—IL6—melanoma	4.31e-06	3.54e-05	CbGpPWpGaD
Probenecid—SLCO1A2—Metabolism—PIK3CB—melanoma	4.29e-06	3.52e-05	CbGpPWpGaD
Probenecid—ABCC3—Metabolism—PTEN—melanoma	4.26e-06	3.5e-05	CbGpPWpGaD
Probenecid—SLCO1A2—Metabolism—PTGS2—melanoma	4.25e-06	3.49e-05	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—PPARG—melanoma	4.24e-06	3.48e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—GNA11—melanoma	4.23e-06	3.47e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	4.23e-06	3.47e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—CD44—melanoma	4.21e-06	3.46e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—GNAQ—melanoma	4.21e-06	3.46e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—melanoma	4.19e-06	3.44e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—FASN—melanoma	4.14e-06	3.4e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—CYP1B1—melanoma	4.14e-06	3.4e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—melanoma	4.09e-06	3.36e-05	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—PIK3CG—melanoma	4.09e-06	3.36e-05	CbGpPWpGaD
Probenecid—ABCC1—Disease—CTNNB1—melanoma	4.09e-06	3.36e-05	CbGpPWpGaD
Probenecid—ABCC5—Metabolism—PIK3CA—melanoma	4.07e-06	3.34e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—SLC5A5—melanoma	4.07e-06	3.34e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism of lipids and lipoproteins—PTEN—melanoma	4.07e-06	3.34e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—CYP1B1—melanoma	4.04e-06	3.32e-05	CbGpPWpGaD
Probenecid—ALB—Hemostasis—VEGFA—melanoma	4.04e-06	3.31e-05	CbGpPWpGaD
Probenecid—ABCC1—Disease—CDKN1A—melanoma	3.99e-06	3.28e-05	CbGpPWpGaD
Probenecid—ALB—Hemostasis—NRAS—melanoma	3.99e-06	3.27e-05	CbGpPWpGaD
Probenecid—ABCC1—Disease—PTEN—melanoma	3.98e-06	3.27e-05	CbGpPWpGaD
Probenecid—ABCC5—Disease—AKT1—melanoma	3.97e-06	3.26e-05	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—PPARG—melanoma	3.95e-06	3.24e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—CD44—melanoma	3.94e-06	3.23e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—GNAQ—melanoma	3.94e-06	3.23e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—PLA2G6—melanoma	3.9e-06	3.2e-05	CbGpPWpGaD
Probenecid—ABCC1—Metabolism—PIK3CB—melanoma	3.86e-06	3.17e-05	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—PIK3CD—melanoma	3.86e-06	3.17e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	3.85e-06	3.16e-05	CbGpPWpGaD
Probenecid—ABCC1—Metabolism—PTGS2—melanoma	3.83e-06	3.14e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—melanoma	3.82e-06	3.13e-05	CbGpPWpGaD
Probenecid—ALB—Hemostasis—MAPK3—melanoma	3.82e-06	3.13e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—ABCB1—melanoma	3.82e-06	3.13e-05	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—ALB—melanoma	3.81e-06	3.13e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—ABCB1—melanoma	3.8e-06	3.12e-05	CbGpPWpGaD
Probenecid—SLC16A1—Metabolism—PIK3CA—melanoma	3.79e-06	3.11e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—CYP1B1—melanoma	3.77e-06	3.1e-05	CbGpPWpGaD
Probenecid—SLCO1A2—Metabolism—PTEN—melanoma	3.71e-06	3.04e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—melanoma	3.65e-06	3e-05	CbGpPWpGaD
Probenecid—ALB—Hemostasis—MAPK1—melanoma	3.63e-06	2.98e-05	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—PIK3CD—melanoma	3.6e-06	2.95e-05	CbGpPWpGaD
Probenecid—ABCC1—Disease—STAT3—melanoma	3.56e-06	2.92e-05	CbGpPWpGaD
Probenecid—ABCC1—Disease—NRAS—melanoma	3.55e-06	2.92e-05	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—ALB—melanoma	3.55e-06	2.91e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—PRKCA—melanoma	3.51e-06	2.88e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—VCAN—melanoma	3.5e-06	2.88e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—PRKCA—melanoma	3.49e-06	2.87e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—ERCC2—melanoma	3.48e-06	2.86e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—ERCC2—melanoma	3.46e-06	2.84e-05	CbGpPWpGaD
Probenecid—ALB—Hemostasis—KRAS—melanoma	3.43e-06	2.82e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—ABCB1—melanoma	3.41e-06	2.8e-05	CbGpPWpGaD
Probenecid—ABCC1—Disease—MAPK3—melanoma	3.4e-06	2.79e-05	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—PIK3CB—melanoma	3.36e-06	2.76e-05	CbGpPWpGaD
Probenecid—ABCC1—Metabolism—PTEN—melanoma	3.34e-06	2.74e-05	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—PTGS2—melanoma	3.33e-06	2.74e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—melanoma	3.33e-06	2.73e-05	CbGpPWpGaD
Probenecid—ABCC5—Metabolism—AKT1—melanoma	3.33e-06	2.73e-05	CbGpPWpGaD
Probenecid—ABCC1—Disease—MYC—melanoma	3.31e-06	2.72e-05	CbGpPWpGaD
Probenecid—ABCC1—Disease—MAPK1—melanoma	3.24e-06	2.66e-05	CbGpPWpGaD
Probenecid—ABCC1—Disease—EGFR—melanoma	3.24e-06	2.66e-05	CbGpPWpGaD
Probenecid—ALB—Hemostasis—PIK3CA—melanoma	3.15e-06	2.59e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—PRKCA—melanoma	3.14e-06	2.57e-05	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—PIK3CB—melanoma	3.13e-06	2.57e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—ERCC2—melanoma	3.11e-06	2.55e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—ABCB1—melanoma	3.11e-06	2.55e-05	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—PTGS2—melanoma	3.11e-06	2.55e-05	CbGpPWpGaD
Probenecid—SLC16A1—Metabolism—AKT1—melanoma	3.09e-06	2.54e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—PRKCA—melanoma	3.06e-06	2.51e-05	CbGpPWpGaD
Probenecid—ABCC1—Disease—KRAS—melanoma	3.06e-06	2.51e-05	CbGpPWpGaD
Probenecid—ALB—Hemostasis—TP53—melanoma	3.05e-06	2.5e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—ERCC2—melanoma	3.04e-06	2.49e-05	CbGpPWpGaD
Probenecid—ABCC3—Metabolism—PIK3CA—melanoma	3e-06	2.47e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—CYP17A1—melanoma	2.96e-06	2.43e-05	CbGpPWpGaD
Probenecid—ALB—Hemostasis—HRAS—melanoma	2.92e-06	2.39e-05	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—PTEN—melanoma	2.91e-06	2.39e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	2.89e-06	2.37e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	2.87e-06	2.36e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—PRKCA—melanoma	2.86e-06	2.35e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—ERCC2—melanoma	2.84e-06	2.33e-05	CbGpPWpGaD
Probenecid—ABCC1—Disease—PIK3CA—melanoma	2.81e-06	2.31e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—GNA11—melanoma	2.79e-06	2.29e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—PIK3CG—melanoma	2.75e-06	2.26e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—PIK3CG—melanoma	2.74e-06	2.25e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—FASN—melanoma	2.73e-06	2.24e-05	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—PTEN—melanoma	2.71e-06	2.22e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—SLC5A5—melanoma	2.69e-06	2.21e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—PPARG—melanoma	2.66e-06	2.18e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—PPARG—melanoma	2.64e-06	2.17e-05	CbGpPWpGaD
Probenecid—SLCO1A2—Metabolism—PIK3CA—melanoma	2.62e-06	2.15e-05	CbGpPWpGaD
Probenecid—ABCC1—Disease—HRAS—melanoma	2.6e-06	2.13e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—GNAQ—melanoma	2.6e-06	2.13e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—CD44—melanoma	2.6e-06	2.13e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	2.58e-06	2.11e-05	CbGpPWpGaD
Probenecid—ALB—Hemostasis—AKT1—melanoma	2.58e-06	2.11e-05	CbGpPWpGaD
Probenecid—ABCC1—Disease—IL6—melanoma	2.49e-06	2.04e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—CYP1B1—melanoma	2.49e-06	2.04e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—PIK3CG—melanoma	2.46e-06	2.02e-05	CbGpPWpGaD
Probenecid—ABCC3—Metabolism—AKT1—melanoma	2.45e-06	2.01e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—PIK3CD—melanoma	2.42e-06	1.99e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—PIK3CD—melanoma	2.41e-06	1.97e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—PIK3CG—melanoma	2.4e-06	1.97e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—ALB—melanoma	2.39e-06	1.96e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—PPARG—melanoma	2.37e-06	1.95e-05	CbGpPWpGaD
Probenecid—ABCC1—Metabolism—PIK3CA—melanoma	2.35e-06	1.93e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	2.35e-06	1.93e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—PPARG—melanoma	2.31e-06	1.9e-05	CbGpPWpGaD
Probenecid—ABCC1—Disease—AKT1—melanoma	2.3e-06	1.88e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—PIK3CG—melanoma	2.24e-06	1.84e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—PPARG—melanoma	2.16e-06	1.77e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—PIK3CD—melanoma	2.16e-06	1.77e-05	CbGpPWpGaD
Probenecid—SLCO1A2—Metabolism—AKT1—melanoma	2.14e-06	1.75e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—ALB—melanoma	2.13e-06	1.75e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—PIK3CB—melanoma	2.11e-06	1.73e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—PIK3CD—melanoma	2.11e-06	1.73e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—PIK3CB—melanoma	2.1e-06	1.72e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—PTGS2—melanoma	2.09e-06	1.72e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—ALB—melanoma	2.08e-06	1.71e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—PTGS2—melanoma	2.08e-06	1.71e-05	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—PIK3CA—melanoma	2.05e-06	1.68e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—ABCB1—melanoma	2.05e-06	1.68e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—PIK3CD—melanoma	1.97e-06	1.62e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—ALB—melanoma	1.94e-06	1.6e-05	CbGpPWpGaD
Probenecid—ABCC1—Metabolism—AKT1—melanoma	1.92e-06	1.58e-05	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—PIK3CA—melanoma	1.91e-06	1.57e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—PRKCA—melanoma	1.89e-06	1.55e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—PIK3CB—melanoma	1.88e-06	1.54e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—ERCC2—melanoma	1.87e-06	1.54e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—PTGS2—melanoma	1.86e-06	1.53e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—PIK3CB—melanoma	1.84e-06	1.51e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—PTEN—melanoma	1.82e-06	1.5e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—PTGS2—melanoma	1.82e-06	1.49e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—PTEN—melanoma	1.81e-06	1.49e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—PIK3CB—melanoma	1.72e-06	1.41e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—PTGS2—melanoma	1.7e-06	1.4e-05	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—AKT1—melanoma	1.67e-06	1.37e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—PTEN—melanoma	1.63e-06	1.34e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—PTEN—melanoma	1.59e-06	1.3e-05	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—AKT1—melanoma	1.56e-06	1.28e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—PTEN—melanoma	1.48e-06	1.22e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—PIK3CG—melanoma	1.48e-06	1.21e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—PPARG—melanoma	1.43e-06	1.17e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—PIK3CD—melanoma	1.3e-06	1.07e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—PIK3CA—melanoma	1.29e-06	1.06e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—ALB—melanoma	1.28e-06	1.05e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—PIK3CA—melanoma	1.28e-06	1.05e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—PIK3CA—melanoma	1.15e-06	9.42e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—PIK3CB—melanoma	1.13e-06	9.29e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—PTGS2—melanoma	1.12e-06	9.21e-06	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—PIK3CA—melanoma	1.12e-06	9.19e-06	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—AKT1—melanoma	1.05e-06	8.62e-06	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—PIK3CA—melanoma	1.05e-06	8.59e-06	CbGpPWpGaD
Probenecid—ALB—Metabolism—AKT1—melanoma	1.04e-06	8.57e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—PTEN—melanoma	9.78e-07	8.03e-06	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—AKT1—melanoma	9.37e-07	7.69e-06	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—AKT1—melanoma	9.15e-07	7.51e-06	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—AKT1—melanoma	8.55e-07	7.02e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—PIK3CA—melanoma	6.9e-07	5.66e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—AKT1—melanoma	5.64e-07	4.63e-06	CbGpPWpGaD
